Results 11 to 20 of about 383 (191)

Results and prospects of rotavirus immunisation in the Russian Federation

Биопрепараты: Профилактика, диагностика, лечение, 2023
Scientific relevance. Rotavirus disease and its consequences remain a leading vaccine-preventable cause of mortality in young children. Russia has not yet included rotavirus immunisation in the national vaccination schedule, but paediatric rotavirus ...
A. S. Korovkin, G. M. Ignatyev
doaj   +1 more source

Assessing the Role of Infant and Toddler MenACWY Immunisation in the UK: Does the Adolescent MenACWY Programme Provide Sufficient Protection?

Vaccines, 2023
A combined Haemophilus influenzae type b (Hib)/meningococcal serogroup C (MenC) vaccine will soon be unavailable in the UK immunisation schedule due to discontinuation by the manufacturer.
Katharina Schley, Jack C. Kowalik, Shannon M. Sullivan, Andrew Vyse, Carole Czudek, Eszter Tichy, Jamie Findlow   +6 more
doaj   +1 more source

Missed Vaccinations in Children during the COVID-19 Pandemic [PDF]

Indian Journal of Neonatal Medicine and Research, 2022
Introduction: During the Coronavirus Disease 2019 (COVID19) pandemic, lockdown was imposed to break the rapid spread of infection which hampered many essential services.
Kiran Basavaraja, Suman Meenakshi Gururaja, Geetha Mannivanan, Santosh Srinivasiah   +3 more
doaj   +1 more source

Optimising DTwP-containing vaccine infant immunisation schedules (OptImms) — a protocol for two parallel, open-label, randomised controlled trials

Trials, 2023
Background Universal immunisation is the cornerstone of preventive medicine for children, The World Health Organisation (WHO) recommends diphtheria-tetanus-pertussis (DTP) vaccine administered at 6, 10 and 14 weeks of age as part of routine immunisation.
Sarah Kelly, Xinxue Liu, Katherine Theiss-Nyland, Merryn Voysey, Sarah Murphy, Grace Li, Mary Nyantaro, Meeru Gurung, Sudha Basnet, Bhishma Pokhrel, Sanjeev M. Bijukchhe, Agnes Eordogh, Ben Gombe, Ayoub Kakande, Simon Kerridge, Geofrey Kimbugwe, Sylvia Kusemererwa, Lawrence Lubyayi, Henry Luzze, Olga Mazur, Yama F. Mujadidi, Shamim Nabukenya, Walter-Rodney Nagumo, Tryphena Nareeba, Rabiullah Noristani, Peter O’Reilly, Andrew Roberts, Ganesh Shah, Sonu Shrestha, Laxman P. Shrestha, Surya B. Thapa, Freddie M. Kibengo, Arun K. Sharma, Alison Elliott, Shrijana Shrestha, Andrew J. Pollard   +35 more
doaj   +1 more source

A randomized controlled trial of heterologous ChAdOx1 nCoV-19 and recombinant subunit vaccine MVC-COV1901 against COVID-19

Nature Communications, 2022
Public safety concern of the ChAdOx1 vaccine has led to an alternative immunisation strategy against SARS-CoV-2, with this heterologous schedule widely adopted and officially recommended in many countries.
Chih-Jung Chen, Lan-Yan Yang, Wei-Yang Chang, Yhu-Chering Huang, Cheng-Hsun Chiu, Shin-Ru Shih, Chung-Guei Huang, Kuan-Ying A. Huang   +7 more
doaj   +1 more source

Using immunisation caregiver journey interviews to understand and optimise vaccination uptake: lessons from Sierra Leone

BMJ Global Health, 2021
Quantitative and qualitative assessments have revealed diverse factors that influence the uptake of childhood immunisation services and shed light on reasons for vaccination delays and refusals. UNICEF and partner organisations developed the Immunisation
Dimitri Prybylski, Lauren E Parmley, Mohamed F Jalloh, Anthony Mansaray, Maria Lahuerta, Benjamin Hickler, Roberta Sutton, Shibani Kulkarni, Oliver Eleeza, Palak Patel, Elisabeth Wilhelm, Laura Conklin, Adewale Akinjeji, Mame Toure, Brent Wolff, Aaron S Wallace   +15 more
doaj   +1 more source

Vaccine programme stakeholder perspectives on a hypothetical single-dose human papillomavirus (HPV) vaccine schedule in low and middle-income countries

Papillomavirus Research, 2018
Background: The World Health Organization (WHO) recommends a 2-dose HPV vaccine schedule for girls aged 9–14 years. As randomised controlled trials assessing the immunogenicity and efficacy of a 1-dose schedule are ongoing, we interviewed immunisation ...
Katherine E. Gallagher, Helen Kelly, Naomi Cocks, Sandra Dixon, Sandra Mounier-Jack, Natasha Howard, Deborah Watson-Jones   +6 more
doaj   +1 more source

Immunisation services in North‑Eastern Nigeria: Perspectives of critical stakeholders to improve uptake and service delivery

Journal of Public Health in Africa, 2023
We investigated the perspectives of parents, health workers (HWs) and traditional medical practitioners (TMPs) on immunisation advocacy, knowledge, attitudes and immuni‑ sation practice and ways of improving immunisation uptake in Borno State, North ...
Semeeh A. Omoleke, Babatunji A. Omotara, Adewale L. Oyeyemi, Omeiza Beida, Samuel O. Etatuvie   +4 more
doaj   +1 more source

Evaluation of strain coverage of the multicomponent meningococcal serogroup B vaccine (4CMenB) administered in infants according to different immunisation schedules

Human Vaccines & Immunotherapeutics, 2019
The 4-component vaccine 4CMenB, developed against invasive disease caused by meningococcal serogroup B, is approved for use in infants in several countries worldwide.
Alessia Biolchi, Sara Tomei, Laura Santini, Jo Anne Welsch, Daniela Toneatto, Nikolaos Gaitatzis, Xilian Bai, Ray Borrow, Marzia Monica Giuliani, Elena Mori, Mariagrazia Pizza   +10 more
doaj   +1 more source

Catch-up immunisation for children in earthquake-affected areas of West Pasaman, Indonesia [PDF]

E3S Web of Conferences
Children are a particularly vulnerable population when exposed to natural disasters and experience increased problems related to physical health, mental health and post-disaster learning.
Syawqi Rahmat, Fitry Yani Finny, Asrawati, Mariko Rinang   +3 more
doaj   +1 more source